Office of Technology Transfer; Notice of meetings, 5565 [2015-01964]
Download as PDF
Federal Register / Vol. 80, No. 21 / Monday, February 2, 2015 / Notices
such payments before funding is offered
to the LRP participant.
Should an IHS Area Office contribute
to the LRP, those funds will be used for
only those sites located in that Area.
Those sites will retain their relative
ranking from the national site-ranking
list. For example, the Albuquerque Area
Office identifies supplemental monies
for dentists. Only the dental positions
within the Albuquerque Area will be
funded with the supplemental monies
consistent with the national ranking and
site index within that Area.
Should an IHS Service Unit
contribute to the LRP, those funds will
be used for only those sites located in
that Service Unit. Those sites will retain
their relative ranking from the national
site-ranking list. For example,
Whiteriver Service Unit identifies
supplemental monies for nurses. The
Whiteriver Service Unit consists of two
facilities, namely the Whiteriver PHS
Indian Hospital and the Cibecue Indian
Health Center. The national ranking will
be used for the Whiteriver PHS Indian
Hospital (Score = 79) and the Cibecue
Indian Health Center (Score = 95). With
a score of 95, the Cibecue Indian Health
Center would receive priority over the
Whiteriver PHS Indian Hospital.
Dated: January 20, 2015.
Yvette Roubideaux,
Acting Director, Indian Health Service.
[FR Doc. 2015–01958 Filed 1–30–15; 8:45 am]
kassilked@mail.nih.gov by Tuesday,
February 17th, 2015. The written
comment should include the
commenter’s name and, when
applicable, professional affiliation.
ADDRESSES: Session 1: February 13,
2015 from 9:30 to 10:00 a.m. https://nih.
webex.com/nih/j.php?MTID=m2a6eb
40ebe096afad861f0b5e941f9bc.
Session 2: February 13, 2015 from
10:00 to 10:30 a.m. https://nih.webex.
com/nih/j.php?MTID=m8c50a
9e8b5454a39b4fa24d9df412fab.
FOR FURTHER INFORMATION CONTACT:
Deborah Kassilke, kassilked@
mail.nih.gov, 301–435–2950.
SUPPLEMENTARY INFORMATION: The
background of the proposed OTT
reorganization is as follows.
The Advisory Committee to the NIH
Deputy Director for Intramural
Research, and the Technology Transfer
Steering Committee (TTSC) recently
assessed OTT to determine how it
services the overall technology transfer
needs of the NIH. The committees
recommended that the authority and
responsibility for the implementation
and execution of patenting and
licensing should be decentralized from
OTT and distributed throughout the
NIH Institutes and Centers (ICs). In
September 2014, the NIH Steering
Committee accepted this
recommendation.
Dated: January 27, 2015.
Lawrence Tabak,
Principal Deputy Director, National Institutes
of Health.
BILLING CODE 4165–16–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2015–01964 Filed 1–30–15; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
Office of Technology Transfer; Notice
of meetings
ACTION:
Notice of meetings.
National Institutes of Health
Notice is hereby given that
the Office of Intramural Research (OIR),
National Institutes of Health (NIH), will
host two webinars to enable public
discussion of its proposal to reorganize
the OIR Office of Technology Transfer
(OTT). The proposal seeks to align
authority and responsibility for the
implementation and execution of
patenting and licensing (P&L) functions
within the NIH Institutes and Centers.
DATES: The first webinar will be held on
February 13th from 9:30 to 10:00 a.m.
The second webinar will be held on
February 13th from 10:00 to 10:30 a.m.
Members of the public wishing to join
a webinar must register via the webinar
link provided. Any interested person
may also file written comments by
sending an email to Deborah Kassilke,
mstockstill on DSK4VPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
19:24 Jan 30, 2015
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Jkt 235001
National Institute of Neurological
Disorders and Stroke, Muscular
Dystrophy Coordinating Committee
Call for Committee Membership
Nominations
The Office of the Secretary of
the Department of Health and Human
Services (HHS) is seeking nominations
of individuals to serve as non-federal
public members on the Muscular
Dystrophy Coordinating Committee.
DATES: Nominations are due by close of
business, February 27, 2015.
ADDRESSES: Nominations must be sent
to Glen Nuckolls, Ph.D., by email to
nuckollg@ninds.nih.gov.
FOR FURTHER INFORMATION CONTACT: Glen
Nuckolls, Ph.D., by email to nuckollg@
ninds.nih.gov.
SUMMARY:
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
5565
The
Muscular Dystrophy Coordinating
Committee (MDCC) is a federal advisory
committee established in accordance
with the Muscular Dystrophy
Community Assistance, Research, and
Education Amendments of 2001 (MD–
CARE Act; Public Law 107–84. The
MD–CARE Act was reauthorized in
2008 by Public Law 110–361, and again
in 2014 by Public Law 113–166. The
2014 reauthorization mandated changes
to the membership of the MDCC,
resulting in the addition of one public
member. Nominations of non-federal
public members will be accepted
between January 30, 2015 and February
27, 2015.
Who is Eligible: Nominations of new
non-federal public members interested
in advancing muscular dystrophy
research and reducing the burden of
disease are encouraged. Selfnominations and nominations of other
individuals are both permitted. Only
one nomination per individual is
required. Multiple nominations for the
same individual will not increase
likelihood of selection. Non-federal
public members may be selected from
the pool of submitted nominations and
other sources as needed to meet
statutory requirements and to form a
balanced committee that represents the
diversity within the muscular dystrophy
community. Those eligible for
nomination include leaders or
representatives of major muscular
dystrophy research, advocacy, and
service organizations, parents or
guardians of individuals with muscular
dystrophy, individuals with muscular
dystrophy and service providers,
educators, researchers, and other
individuals with professional or
personal experience with muscular
dystrophy. In accordance with White
House Office of Management and
Budget guidelines (FR Doc. 2014–
19140), federally-registered lobbyists are
not eligible.
Committee Composition: In
accordance with the Committee’s
authorizing statute, 2⁄3 of members of the
Coordinating Committee shall represent
government agencies and 1⁄3 of members
shall be public members ‘‘including a
broad cross section of persons affected
with muscular dystrophies including
parents or legal guardians, affected
individuals, researchers, and
clinicians.’’
The Department strives to ensure that
the membership of HHS Federal
advisory committees is fairly balanced
in terms of points of view represented
and the committee’s function. Every
effort is made to ensure that the views
of women, all ethnic and racial groups,
SUPPLEMENTARY INFORMATION:
E:\FR\FM\02FEN1.SGM
02FEN1
Agencies
[Federal Register Volume 80, Number 21 (Monday, February 2, 2015)]
[Notices]
[Page 5565]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-01964]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of Technology Transfer; Notice of meetings
ACTION: Notice of meetings.
-----------------------------------------------------------------------
SUMMARY: Notice is hereby given that the Office of Intramural Research
(OIR), National Institutes of Health (NIH), will host two webinars to
enable public discussion of its proposal to reorganize the OIR Office
of Technology Transfer (OTT). The proposal seeks to align authority and
responsibility for the implementation and execution of patenting and
licensing (P&L) functions within the NIH Institutes and Centers.
DATES: The first webinar will be held on February 13th from 9:30 to
10:00 a.m. The second webinar will be held on February 13th from 10:00
to 10:30 a.m. Members of the public wishing to join a webinar must
register via the webinar link provided. Any interested person may also
file written comments by sending an email to Deborah Kassilke,
kassilked@mail.nih.gov by Tuesday, February 17th, 2015. The written
comment should include the commenter's name and, when applicable,
professional affiliation.
ADDRESSES: Session 1: February 13, 2015 from 9:30 to 10:00 a.m. https://nih.webex.com/nih/j.php?MTID=m2a6eb40ebe096afad861f0b5e941f9bc.
Session 2: February 13, 2015 from 10:00 to 10:30 a.m. https://nih.webex.com/nih/j.php?MTID=m8c50a9e8b5454a39b4fa24d9df412fab.
FOR FURTHER INFORMATION CONTACT: Deborah Kassilke,
kassilked@mail.nih.gov, 301-435-2950.
SUPPLEMENTARY INFORMATION: The background of the proposed OTT
reorganization is as follows.
The Advisory Committee to the NIH Deputy Director for Intramural
Research, and the Technology Transfer Steering Committee (TTSC)
recently assessed OTT to determine how it services the overall
technology transfer needs of the NIH. The committees recommended that
the authority and responsibility for the implementation and execution
of patenting and licensing should be decentralized from OTT and
distributed throughout the NIH Institutes and Centers (ICs). In
September 2014, the NIH Steering Committee accepted this
recommendation.
Dated: January 27, 2015.
Lawrence Tabak,
Principal Deputy Director, National Institutes of Health.
[FR Doc. 2015-01964 Filed 1-30-15; 8:45 am]
BILLING CODE 4140-01-P